Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AKTX

Akari Therapeutics Plc ADR

Jun 12 • 01:34PM ET

14.03

-0.79 -5.33 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: IKT NBP NERV NVCT ALXO BCYC CGEN FATE FHTX CDXS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-18.86	Insider Own	0.40%	Shs Outstand	1.14M	Perf Week	-6.90%
Market Cap	15.99M	Forward P/E	-	EPS next Y	-4.68	Insider Trans	0.00%	Shs Float	1.14M	Perf Month	345.40%
Enterprise Value	13.89M	PEG	-	EPS next Q	-1.39	Inst Own	14.65%	Short Float	10.66%	Perf Quarter	53.03%
Income	-28.00M	P/S	-	EPS this Y	72.10%	Inst Trans	-47.98%	Short Ratio	0.16	Perf Half Y	-7.72%
Sales	0.00M	P/B	1.12	EPS next Y	18.89%	ROA	-66.00%	Short Interest	0.12M	Perf YTD	21.37%
Book/sh	12.56	P/C	5.65	EPS next 5Y	32.82%	ROE	-155.01%	52W High	50.40 -72.16%	Perf Year	-70.04%
Cash/sh	2.48	P/FCF	-	EPS past 3/5Y	- -	ROIC	-194.71%	52W Low	3.02 365.34%	Perf 3Y	-88.98%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	9.95% 30.94%	Perf 5Y	-99.01%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	13.85%	Oper. Margin	-	ATR (14)	2.69	Perf 10Y	-99.88%
Dividend Ex-Date	-	Quick Ratio	0.27	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	55.83	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.27	EPS Q/Q	-75.83%	SMA20	8.90%	Beta	1.34	Target Price	33.50
Payout	-	Debt/Eq	0.05	Sales Q/Q	-	SMA50	72.08%	Rel Volume	0.20	Prev Close	14.82
Employees	6	LT Debt/Eq	0.00	Earnings	May 14	SMA200	-14.27%	Avg Volume	756.30K	Price	14.03
IPO	May 07, 2013	Option/Short	No / Yes	EPS/Sales Surpr.	0.00% -	Trades		Volume	95,066	Change	-5.33%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)